(Q33829284)

29 July 2017

title

Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases (English)

1 reference

29 July 2017

Zhihong Chi

1

1 reference

29 July 2017

Siming Li

2

1 reference

29 July 2017

Xinan Sheng

3

1 reference

29 July 2017

Lu Si

4

1 reference

29 July 2017

Chuanliang Cui

5

1 reference

29 July 2017

Mei Han

6

1 reference

29 July 2017

Jun Guo

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

25 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

page(s)

85

1 reference

Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Melanoma arising in African-, Asian-, Latino- and Native-American populations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

4 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Melanoma incidence and mortality in Scotland 1979-2003.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Head and neck mucosal melanoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Updated statistical data for malignant melanoma in Japan

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Skin cancer in African Americans

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Acral lentiginous melanoma. A clinicopathologic entity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056833

Ethnic differences among patients with cutaneous melanoma.

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-85

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-85

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-85

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-85

Malignant melanoma in Taiwan: a prognostic study of 181 cases

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349197

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A population-based validation of the American Joint Committee on Cancer melanoma staging system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349197

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-11-85

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference